BioSpace News Archive

A new poll from WebMD finds that concern about coronavirus is on the rise, with more people worried about the pandemic now than at any point since early April.

illuminate.health, a digital health assistant platform designed to help people live healthier, today announced the general availability of Recovery Coach, an artificial intelligence (AI)-powered digital health assistant and evidence-based addiction treatment resource, to virtually support patients in their journey towards substance use disorder (SUD) recovery.

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a worldwide reputation for top-rated customer service and support, today announced that its Ortho Care™ holistic service and support program was ranked No. 1 in the diagnostics industry for a fifth straight year.

The inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum successfully concluded in Shanghai on July 17, at which more than 700 authoritative researchers and corporate leaders shared insights on the future growth of the cell and gene industry.

The global chordoma disease therapeutics market is estimated to be valued at US$ 5,296.31 million in 2020 and is expected to exhibit a CAGR of 6.7% over the forecast period (2020-2027). Key Trends and Analysis: Key trends in the market include increasing research and development activities, increasing number of cases of chordoma, and increasing launches of generic versions of therapeutic drugs. Although chordoma

HOUSTON, July 21, 2020 /PRNewswire/ -- FibroGenesis announced today new data supporting use of its PneumoBlast™ product in the battle against COVID-19

Novum Pharmaceutical Research Services announced an expansion of its services in North America. Novum, one of the world’s leading Contract Research Organizations for almost fifty years, has consolidated Lambda Therapeutic Research’s Toronto, Canada clinic and bioanalytical laboratory into Novum operations.

Cerevance, a private drug discovery and development company focused on brain diseases, has expanded its Series B financing round, adding $20 million to the $45 million that it announced in April. With this second closing, UPMC Enterprises, Casdin Capital and Dolby Family Ventures joined the company’s investor base, while Foresite Capital added to its investment made in the first closing. Cerevance’s previous closing also included GV (formerly Google Ve

Healthcare technology company TRIMEDX, an industry-leading provider of clinical asset management solutions for health systems’ clinical engineering services, announced a strategic partnership with Medigate―a dedicated medical device security and asset management solution firm―to meet the unique demands of clinical asset management (CAM) and medical device safety and security for healthcare systems.

An article written in the July 18th, 2020 Knowridge Science Report said a recent review study at Cardiff University and elsewhere detailed that researchers found that certain mouthwashes used in the dental community may help destroy the lipid envelope of Coronaviruses. This would combat virus replication in the mouth and throat.